Chemical Structure : PE859
CAS No.: 1402727-29-0
货号: PC-43143Not For Human Use, Lab Use Only.
PE859 is a novel, orally active tau aggregation inhibitor that inhibits the heparin-induced aggregation of both 3RMBD and full length tau with IC50 of 0.81 uM and 2.23 uM, respectively.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥1280 | In stock | |
| 10 mg | ¥1980 | In stock | |
| 25 mg | ¥3280 | In stock | |
| 50 mg | ¥5280 | In stock | |
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PE859 is a novel, orally active tau aggregation inhibitor that inhibits the heparin-induced aggregation of both 3RMBD and full length tau with IC50 of 0.81 uM and 2.23 uM, respectively.
PE859 also inhibits amyloid β (Aβ) aggregation with IC50 of 1.2 uM.
PE859 significantly reduces sarkosyl-insoluble aggregated tau along with the prevention of onset and progression of the motor dysfunction in JNPL3 P301L-mutated human tau transgenic mice.
| 分子量 | 448.5157 | |
| 分子式 | C28H24N4O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
DMSO: ≥ 30 mg/mL |
|
| Chemical Name/SMILES |
1H-Indole, 6-[(1E)-2-[5-[(1E)-2-[2-methoxy-4-(2-pyridinylmethoxy)phenyl]ethenyl]-1H-pyrazol-3-yl]ethenyl]- |
|
1. Okuda M, et al. PLoS One. 2015 Feb 6;10(2):e0117511.
2. Okuda M, et al. Bioorg Med Chem Lett. 2016 Oct 15;26(20):5024-5028.
3. Okuda M, et al. J Alzheimers Dis. 2017;59(1):313-328.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright